These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Development and implementation of a comprehensive, criteria-based drug-use review program. Todd MW; Keith TD; Foster MT Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089 [TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. Paskovaty A; Pflomm JM; Myke N; Seo SK Int J Antimicrob Agents; 2005 Jan; 25(1):1-10. PubMed ID: 15620820 [TBL] [Abstract][Full Text] [Related]
8. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Rüttimann S; Keck B; Hartmeier C; Maetzel A; Bucher HC Clin Infect Dis; 2004 Feb; 38(3):348-56. PubMed ID: 14727204 [TBL] [Abstract][Full Text] [Related]
9. Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins. Barriere SL Am J Hosp Pharm; 1986 Mar; 43(3):625-9. PubMed ID: 3706317 [TBL] [Abstract][Full Text] [Related]
10. Influencing the prescribing of antimicrobial agents without a formulary system. Ham CW Am J Hosp Pharm; 1992 Dec; 49(12):2909, 2914. PubMed ID: 1481790 [No Abstract] [Full Text] [Related]
11. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital. Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements. Thrasher CM; Stefl ME; Dorner FH Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621 [TBL] [Abstract][Full Text] [Related]
13. Controlling the costs of antibiotic resistance. North D Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459 [TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process. Skaer TL Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial formulary management: a case study in a teaching hospital. Wright DB Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570 [TBL] [Abstract][Full Text] [Related]
16. [Clinical results and costs due to improved antibiotics policies]. Gyssens IC; Kullberg BJ; van der Meer JW Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774 [TBL] [Abstract][Full Text] [Related]
18. The extended-spectrum penicillins: microbiologic, utilization, and cost review in a community hospital. Stein GE; VanderLinde J; Mummaw N; Leader I; Sugarman B Hosp Pharm; 1989 Sep; 24(9):701-4. PubMed ID: 10295542 [TBL] [Abstract][Full Text] [Related]
19. Effect of a targeted antibiotic advisory consult program on hospital antibiotic costs. Murray MD; Kohler RB; Main JW Hosp Formul; 1988 Jun; 23(6):518-24, 529-30. PubMed ID: 10287850 [TBL] [Abstract][Full Text] [Related]
20. Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital. Rapp RP; Evans ME; Martin C; Ofotokum I; Empey KL; Armitstead JA Curr Med Res Opin; 2004 Apr; 20(4):469-76. PubMed ID: 15119984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]